Literature DB >> 9988680

The yeast frataxin homologue mediates mitochondrial iron efflux. Evidence for a mitochondrial iron cycle.

D C Radisky1, M C Babcock, J Kaplan.   

Abstract

Mutations in the nuclear gene encoding the mitochondrial protein frataxin are responsible for the neurological disorder Friedreich ataxia (FA). Yeast strains with a deletion in the frataxin homologue YFH1 accumulate excess iron in mitochondria and demonstrate mitochondrial damage. We show that in the absence of YFH1, mitochondrial damage is proportional to the concentration and duration of exposure to extracellular iron, establishing mitochondrial iron accumulation as causal to mitochondrial damage. Reintroduction of YFH1 results in the rapid export of accumulated mitochondrial iron into the cytosol as free, non-heme bound iron, demonstrating that mitochondrial iron in the yeast FA model can be made bioavailable. These results demonstrate a mitochondrial iron cycle in which Yfh1p regulates mitochondrial iron efflux.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988680     DOI: 10.1074/jbc.274.8.4497

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Friedreich's ataxia is a mitochondrial disorder.

Authors:  J Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Antioxidant enzymes in blood of patients with Friedreich's ataxia.

Authors:  G Tozzi; M Nuccetelli; M Lo Bello; S Bernardini; L Bellincampi; S Ballerini; L M Gaeta; C Casali; A Pastore; G Federici; E Bertini; F Piemonte
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

3.  Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia.

Authors:  J Adamec; F Rusnak; W G Owen; S Naylor; L M Benson; A M Gacy; G Isaya
Journal:  Am J Hum Genet       Date:  2000-08-04       Impact factor: 11.025

Review 4.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

Review 5.  Friedreich ataxia: an overview.

Authors:  M B Delatycki; R Williamson; S M Forrest
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

Review 6.  Mitochondrial metals as a potential therapeutic target in neurodegeneration.

Authors:  A Grubman; A R White; J R Liddell
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 7.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

8.  Mitochondrial functioning of constitutive iron uptake mutations in Cryptococcus neoformans.

Authors:  Eric S Jacobson; Amanda J Troy; Karin J Nyhus
Journal:  Mycopathologia       Date:  2005-01       Impact factor: 2.574

9.  Inhibition of Fe-S cluster biosynthesis decreases mitochondrial iron export: evidence that Yfh1p affects Fe-S cluster synthesis.

Authors:  Opal S Chen; Shawn Hemenway; Jerry Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

10.  Zinc suppresses the iron-accumulation phenotype of Saccharomyces cerevisiae lacking the yeast frataxin homologue (Yfh1).

Authors:  Renata Santos; Andrew Dancis; David Eide; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.